IDH2 and chondrosarcoma: Other retrospective studies reported IDH mutations (mainly IDH1 R132 followed by IDH2 R172) in 34% to 67% of patients with chondrosarcomas, more frequently in high-grade than in low-grade chondrosarcomas [1, 9, 28, 32, 51] (Table 3).